Role of Calcium-Activated Neutral Protease (Calpain) in Cell Death in Cultured Neonatal Rat Cardiomyocytes During Metabolic Inhibition
- 1 June 1995
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation Research
- Vol. 76 (6) , 1071-1078
- https://doi.org/10.1161/01.res.76.6.1071
Abstract
Calcium-activated neutral protease (CANP), also known as calpain, has been implicated in the development of cell death in ischemic hearts. CANP is thought to be activated by the calcium overload that develops during ischemia. We studied the involvement of CANP in cell death in cultured neonatal rat cardiomyocytes during metabolic inhibition (5 mmol/L NaCN+10 mmol/L 2-deoxyglucose). First, we isolated CANP using ion exchange and affinity chromatography. Then the efficacy of the CANP inhibitors calpain I inhibitor, leupeptin, and E64 to inhibit isolated CANP activity was tested with the use of fluorescently labeled β-casein as a substrate. The IC 50 for the inhibitors was between 2.1 and 56 μmol/L. Uptake of the inhibitors by intact cells was assessed with the use of 99m Tc-radiolabeled inhibitors. The calculated intracellular inhibitor concentrations were sufficiently high to yield substantial inhibition of intracellular CANP activity. Intracellular CANP activity was measured directly with the use of the cell-permeant fluorogenic CANP-specific substrate N -succinyl-Leu-Leu-Val-Tyr-7-amido-4-methyl-coumarin. During metabolic inhibition, intracellular CANP activity was increased compared with control incubation. The time course of CANP activation was compatible with that of the rise in [Ca 2+ ] i , as measured by fura 2 and digital imaging fluorescence microscopy. Calpain I inhibitor and leupeptin inhibited intracellular CANP activity both during metabolic inhibition and control incubation, whereas E64 did not. Despite their substantial inhibition of intracellular CANP activity, calpain I inhibitor and leupeptin did not attenuate cell death during metabolic inhibition. We therefore conclude that intracellular CANP in cardiomyocytes is activated during metabolic inhibition, but it does not play a major role in the development of cell death.Keywords
This publication has 30 references indexed in Scilit:
- The labeling of proteins and LDL with 99mTc: a new direct method employing KBH4 and stannous chlorideNuclear Medicine and Biology, 1993
- Cytosolic Ca2+ concentration and pH of diabetic rat myocytes during metabolic inhibitionJournal of Molecular and Cellular Cardiology, 1992
- Application of stereological analysis of cell volume to isolated myocytes in culture with and without adrenergic innervationThe Anatomical Record, 1991
- A method to quantitate cell numbers of muscle cells and non-muscle cells in homogenised heart cell culturesCardiovascular Research, 1989
- Enzyme release from chick myocytes during hypoxia and reoxygenation: Dependence on pHJournal of Molecular and Cellular Cardiology, 1989
- The formation of plasma membrane blebs in hepatocytes exposed to agents that increase cytosolic Ca2+ is mediated by the activation of a non‐lysosomal proteolytic systemFEBS Letters, 1986
- Purification and characterizaton of two distinct Ca2+-activated proteinases from hearts of hypertensive ratsBiochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology, 1985
- Effect of NCO-700, an Inhibitor of Protease, on Myocardial pH Decreased by Coronary Occlusion in DogsPharmacology, 1985
- Role of cellular proteinases in acute myocardial infarction II. influence of in vivo suppression of myocardial proteolysis by antipain, leupeptin and pepstatin on myocardial infarct size in the ratJournal of the American College of Cardiology, 1983
- Reduction of experimentally produced acute myocardial infarction size by a new synthetic inhibitor, NCO-700, against calcium-activated neutral protease.Japanese Heart Journal, 1982